News | January 31, 2014

PICSO Impulse System Four Month Follow-Up Shows Infarct Size-Reduction

Miracor Medical PICSO Impulse System Clinical Trial Cath Lab

Coronary sinus pressure increase during two cycles of PICSO (clinical data from the Prepare PICSO study).

January 31, 2014 — Miracor Medical Systems completed four months’ follow-up of patients enrolled in the “Prepare RAMSES” clinical trial of PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) System. PICSO is designed to improve myocardial perfusion following primary PCI (Percutaneous Coronary Intervention, or angioplasty). Interim data from early results indicate a strong trend towards a larger reduction in infarct for patients receiving the PICSO therapy in complement with primary PCI. A total of 30 patients have successfully enrolled in the clinical trial, with no device-related adverse events. 
The study is underway in several European centers with Principal Investigator Jan J. Piek, M.D., Ph.D., professor of interventional cardiology and director of the Heart Centre, Academic Medical Centre, University of Amsterdam. Miracor Medical is expanding PICSO’s CE marking throughout Europe. 
The Miracor PICSO Impulse System is designed to treat acute heart attack STEMI (ST-segment elevation myocardial infarction) patients in complement to coronary angioplasty. 
For more information:

Related Content

Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init